SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  

Health Sciences Group Inc · 8-K · For 6/28/06

Filed On 6/29/06 4:02pm ET   ·   SEC File 333-65180   ·   Accession Number 1019687-6-1566

  in   Show  and 
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

 6/29/06  Health Sciences Group Inc         8-K{1,9}    6/28/06    2:14                                     Publicease Inc/FA

Current Report   ·   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     16K 
 2: EX-99.1     Employment Agreement Between Health Sciences        HTML     55K 
                          Group, Inc. and Stuart Avery Gold Dated                
                          June 14, 2006                                          


8-K   ·   Current Report


This is an EDGAR HTML document rendered as filed.  [ Alternative Formats ]


  Current Report  
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 28, 2006
 
 

Health Sciences Group, Inc.

(Exact name of registrant specified in charter)
 
 
   
91-2079221
(State of
Incorporation)
 
(Commission File
Number)
 
(IRS Employer
Identification No.)
 

Howard Hughes Center
6080 Center Drive, 6th Floor
Los Angeles, CA 90045
(Address of principal executive offices) (Zip Code)
 
(310) 242-6700
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 
 
 
 
1

 
 

Item 1.01. Entry into a Material Definitive Agreement.


Mr. Gold will receive an annual base salary of $200,000 with the opportunity to receive raises of not less than 10% of the base salary subject to the achievement of mutually agreed upon performance milestones. Under the terms of the Employment Agreement, Mr. Gold is be entitled to receive a cash bonus for each fiscal year that occurs during his term, so long as HESG generates a minimum of $1,000,000 in earnings before interest, taxes, depreciation and amortization (“EBITDA”). Mr. Gold will also receive incentive stock options to purchase up to an aggregate of 6% of the number of shares of HESG’s common stock issued and outstanding immediately following the closing of the next equity financing. The first 3% option shall have an exercise price equal to the closing price of the common stock on the date that the Employment Agreement is approved by the Board of Directors and the term of such options shall be 10 years and vests upon the achievement of certain mutually agreed-upon milestones during his term. The second 3% option shall have an exercise price equal to the price paid by the participants in the next equity financing and the term of the option shall be five years and vests by one-third on each anniversary date over his term. HESG may terminate the  Employment  Agreement at any time with 90 days notice upon payment of the lesser of (i) Mr. Gold’s salary through the remainder of his term or (ii) 12 months of Mr. Gold’s base salary.
 
 

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

 
99.1
Employment Agreement between Health Sciences Group, Inc. and Stuart Avery Gold dated June 14, 2006


 
 
 
 
 
2

 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     
  HEALTH SCIENCES GROUP, INC.
 
 
 
 
 
 
Date: June 29, 2006 By:   /s/ Fred E. Tannous
 
 
Fred E. Tannous
Co-Chairman
Principal Financial Officer

 
 
 
3

Dates Referenced Herein   and   Documents Incorporated By Reference

This 8-K Filing   Date   Other Filings
6/14/06
For The Period Ended6/28/06
Filed On / Filed As Of6/29/06
 
TopList All Filings


Filing Submission   -   Alternative Formats (Word / Rich Text, HTML, Plain Text, SGML, XML, et al.)
Copyright © 2008 Fran Finnegan & Company  All Rights Reserved.
www.secinfo.com - Thu, 20 Nov 2008 07:49:53.1 GMT - Privacy - Help